The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Digital tools to evaluate symptoms – A special interest group

A person wearing an activity tracker and a man sittning with an iPad. Photo collage.
A wide variety of digital tools can be used to monitor symptoms of neurodegenerative diseases. Pictures generated with Gencraft.

Digital tools within healthcare are developing faster than ever before. Therefore, MultiPark researchers gather across groups to develop implementable tools for the diagnosis and prognosis of neurodegenerative disorders. “Digital tools to reliably evaluate cognitive and neurological symptoms” is a new special interest group (SIG) convened by Maria H Nilsson. Here, she tells about the group’s vision.

Can you shortly describe the research topics included in your SIG? 

“This SIG targets digital tools that measures cognitive and motor symptoms in Alzheimer´s disease and Parkinson’s disease. We are specifically interested in their diagnostic and prognostic value, the ability to track disease progression, and to detect effects of interventional studies as well as their implementation in clinical practice.”

Which of MultiPark’s strategic goals does it best align with?

“By using digital tools alone or in combination with other measures, we anticipate gaining an increased understanding of disease mechanisms and progression, including identifying factors resulting in resilience to disease changes. This will help to understand the origins and progression of neurodegenerative disease. Additionally, we will identify accurate, cost-effective, and timely diagnostic and prognostic means by using digital tools.

These can also be used to improve the ability to detect: individuals suitable for specific interventions, therapeutic effects, and an unmet medical need.”  

What are your overarching goals?

“Our goals are to develop and evaluate digital tools for the diagnosis and prognosis of Alzheimer’s and Parkinson’s disease, as well as for tracking the progression of neurodegenerative diseases.” 

What activities do you plan?

“We plan to organize a seminar each semester.”

How many early-career researchers (PhD students, postdocs) are affiliated with this SIG?

“15.”

How do you think that early-career researchers can contribute to the SIG?

“They may attend seminars and contribute to development, pilot-testing and implementation.”